Nuvilex Completes First Sale of Last Shot Hangover ...( ...),Health

CHERRY HILL, N.J., July 15 /PRNewswire-FirstCall/ -- Nuvilex, Inc. (OTC Bulletin Board: NVLX), announced today that it completed its first sale of its Last Shot Hangover Remedy. The sale, a 36 shot case of Last Shot Hangover Remedy(TM), was made to a local bar establishment by the first of Nuvilex' fifteen new commission sales representatives. The sale marks Nuvilex' official launch of its Last Shot Hangover Remedy(TM) across the U.S., concentrating in major markets in the following order: Philadelphia, New York City, Miami, Chicago, Las Vegas, San Francisco, Los Angeles, San Diego, Boston, Washington, DC, Atlanta, New Orleans, Dallas, Phoenix, and Seattle. The initial target customers are the approximate 70,000 bar establishments in the US. The Company, through third party distributor agreements, will expand to restaurants, clubs, resort hotels and international markets later this year. Direct to consumer Internet sales will commence in August 2009.

Last Shot Hangover Remedy(TM) is a calorie-free, liquid, nutritional supplement that contains a concentrated blend of vitamins, essential amino acids, and other beneficial ingredients. Last Shot Hangover Remedy(TM) helps the body to combat symptoms that are associated with alcohol-induced hangovers, including nausea, fatigue, and headache. Last Shot Hangover Remedy(TM) retails for $4.00 per three quarter ounce shot. Approximately 35 hangover remedy products are currently sold worldwide, generally through pharmacies. Nuvilex' "at the bar" distribution strategy is a market differentiator and provides a competitive advantage that ideally fits with the unanticipated consequences of excessive alcohol consumption. The total potential market size in the US for hangover remedy products is estimated to be $10-50 million per year. The Company forecasts $1 to $3 million in Last Shot Hangover Remedy(TM) sales for FY 2010
'/>"/>